Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D3VT
|
||||
Former ID |
DNC013137
|
||||
Drug Name |
Dihydrexidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Psychotic disorders [ICD9: 290-299; ICD10:F20-F29] | Phase 1/2 | [532900] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H17NO2
|
||||
Canonical SMILES |
C1CC2=CC(=C(C=C2C3C1NCC4=CC=CC=C34)O)O
|
||||
InChI |
1S/C17H17NO2/c19-15-7-10-5-6-14-17(13(10)8-16(15)20)12-4-2-1-3-11(12)9-18-14/h1-4,7-8,14,17-20H,5-6,9H2
|
||||
InChIKey |
BGOQGUHWXBGXJW-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 137417-08-4
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Dopamine D1 receptor | Target Info | Inhibitor | [528571] | |
PANTHER Pathway | Dopamine receptor mediated signaling pathway | ||||
PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.